Organigram Global (OGI) Notes Payables (2021 - 2026)

Organigram Global (OGI) posted quarterly Notes Payables of $10.3 million for Q1 2026, down 13.93% on a QoQ basis from $12.0 million in Q4 2025.

Organigram Global (OGI) Notes Payables (2021 - 2026) Analysis & Trends

Organigram Global (OGI) has reported Notes Payables for 3 consecutive years, with $10.3 million the latest figure, recorded in Q1 2026.

  • Quarterly Notes Payables changed N/A year-over-year to $10.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $10.3 million (changed N/A YoY) and the FY2025 annual result came in at $12.0 million, changed N/A from the prior year.
  • Notes Payables slipped to $10.3 million in Q1 2026 per OGI's latest filing, from $12.0 million in the prior quarter.
  • Over the last five years, Notes Payables for OGI reached as high as $21.0 million in Q3 2025 and fell as low as $10.3 million in Q1 2026.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Haleon 87.22 Bn 85.35 Bn -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn
10 Organigram Global 89.89 Mn 122.96 Mn 28.97 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 10.31 Mn
Dec 31, 2025 11.98 Mn
Sep 30, 2025 20.95 Mn
Nov 30, 2021 24.83 Mn
Aug 31, 2021 37.53 Mn
May 31, 2021 44.73 Mn